NASDAQ$RXST
Rxsight Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
RxSight Inc reported Q2 2025 revenue of $33.6 million and a net loss of $11.8 million.
RxSight Inc delivered Q2 2025 revenue of $33.6 million, down 3.6% year-over-year, driven by lower LDD sales partially offset by higher LAL volume. The company reported a net loss of $11.8 million and an operating loss of $14.0 million. Cash and short-term investments totaled $227.5 million at quarter end.
- Revenue declined 3.6% to $33.6 million as LDD sales fell 49% to 40 units while LAL implants rose 13% to 27,380 units.
- Gross margin improved to 74.9% from 69.5% due to favorable product mix and operating leverage.
- Net loss widened to $11.8 million from $6.1 million in the prior-year quarter.
- Installed LDD base reached 1,084 units with $227.5 million in cash and short-term investments supporting operations.
Headline financials
Revenue & EPS history
Rxsight · Revenue · Quarterly
$33.6M
Revenue by segment
Rxsight · $33.6M total across 3 segments · Q2 2025
- LAL$27M—80.3%
- LDD (incl. training)$5.13M—15.3%
- Service, warranty & accessories$1.5M—4.5%
Forward guidance
Management expects to return to revenue growth in absolute dollars through expansion of the sales organization and increased LAL utilization.
Tailwinds
- Realigned commercial structure to drive existing customer LAL growth
- Strong cash position of $227.5 million supports operations
Headwinds
- Slower LDD adoption due to reduced LAL growth over prior nine months
- Broader economic uncertainty impacting new customer acquisitions
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports
-1.1%
Avg return
Earnings day
-2.6%
Avg return
5 days after
+2.8%
Avg return
30 days after
45%
9 / 20 earnings
Positive
+15.1%
Q3 2022
Best reaction
-16.1%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -6.6% | -21.6% | -31.1% | |
| Q4 2025 | -10.1% | -13.5% | -28.9% | |
| Q3 2025 | +8.7% | +16.3% | +46.7% | |
| Q1 2025 | -11.2% | -11.4% | +0.9% | |
| Q4 2024 | -0.8% | -7.8% | -9.1% | |
| Q3 2024 | -12.3% | -16.9% | -21.2% | |
| Q2 2024 | +14.6% | +21.5% | +29.0% | |
| Q1 2024 | +0.8% | -3.8% | -5.0% | |
| Q4 2023 | -5.8% | -3.2% | -10.9% | |
| Q3 2023 | +1.8% | +9.5% | +40.8% | |
| Q2 2023 | -1.5% | -6.3% | -1.8% | |
| Q1 2023 | +9.0% | +18.3% | +34.0% | |
| Q4 2022 | +9.7% | +4.5% | +17.9% | |
| Q3 2022 | +15.1% | +14.6% | +18.1% | |
| Q2 2022 | -2.9% | -8.3% | -13.3% | |
| Q1 2022 | -4.3% | -3.0% | +34.9% | |
| Q4 2021 | +1.4% | -3.2% | +1.8% | |
| Q3 2021 | +3.7% | -0.8% | -4.0% | |
| Q2 2021 | -16.1% | -18.4% | -21.1% | |
| Q4 2020 | -16.1% | -18.4% | -21.1% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro